Skip to content
10-K

Annual Report

PSYCHEMEDICS CORPORATION

0001171843-25-001658

← back to feed
Filed
Mar 24, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 24, 2025 6.11M sh
Shares Diluted FY 2024 · Dec 31, 2024 5.87M sh
Shares Diluted FY 2024 · Dec 31, 2023 5.74M sh
Stock Repurchased FY 2024 · Dec 31, 2024 $2.56M
Stock Repurchased FY 2024 · Dec 31, 2023 $0
Dividends Paid FY 2024 · Dec 31, 2024 $0
Dividends Paid FY 2024 · Dec 31, 2023 $799K
Capex FY 2024 · Dec 31, 2024 $51K
Capex FY 2024 · Dec 31, 2023 $157K
Operating Cash Flow FY 2024 · Dec 31, 2024 $929K
Operating Cash Flow FY 2024 · Dec 31, 2023 −$1.48M
Short Term Debt FY 2024 · Dec 31, 2024 $0
Short Term Debt FY 2024 · Dec 31, 2023 $305K
Cash And Equivalents FY 2024 · Dec 31, 2024 $1.42M
Cash And Equivalents FY 2024 · Dec 31, 2023 $1.96M
Stockholders Equity FY 2024 · Dec 31, 2024 $5.13M
Stockholders Equity FY 2024 · Dec 31, 2023 $6.67M
Stockholders Equity FY 2024 · Dec 31, 2022 $10.77M
Current Liabilities FY 2024 · Dec 31, 2024 $2.71M
Current Liabilities FY 2024 · Dec 31, 2023 $4.71M
Total Liabilities FY 2024 · Dec 31, 2024 $3.19M
Total Liabilities FY 2024 · Dec 31, 2023 $5.65M
Current Assets FY 2024 · Dec 31, 2024 $4.94M
Current Assets FY 2024 · Dec 31, 2023 $6.81M
Total Assets FY 2024 · Dec 31, 2024 $8.32M
Total Assets FY 2024 · Dec 31, 2023 $12.33M
Eps Basic FY 2024 · Dec 31, 2024 −$0.32
Eps Basic FY 2024 · Dec 31, 2023 −$0.72
Sga Expense FY 2024 · Dec 31, 2024 $5.7M
Sga Expense FY 2024 · Dec 31, 2023 $7.19M
Rd Expense FY 2024 · Dec 31, 2024 $749K
Rd Expense FY 2024 · Dec 31, 2023 $1.14M
Net Income FY 2024 · Dec 31, 2024 −$1.86M
Net Income FY 2024 · Dec 31, 2023 −$4.15M
Operating Income FY 2024 · Dec 31, 2024 −$1.89M
Operating Income FY 2024 · Dec 31, 2023 −$2.92M
Gross Profit FY 2024 · Dec 31, 2024 $7.1M
Gross Profit FY 2024 · Dec 31, 2023 $8.41M
Cost Of Revenue FY 2024 · Dec 31, 2024 $12.58M
Cost Of Revenue FY 2024 · Dec 31, 2023 $13.69M